Literature DB >> 10225332

Cognition and neuropathology in schizophrenia.

S E Arnold1.   

Abstract

Clinical, neuropsychological and neuropathological avenues of research have advanced in concert to increase our understanding of schizophrenia. Progress in four general areas of investigation will be reviewed: (i) fronto-temporal-limbic dysfunction; (ii) abnormal connectivity or 'miswiring'; (iii) aberrant neurodevelopment; and (iv) neurodegeneration and neural injury. The challenge for post-mortem research is to identify the molecular pathways in which abnormalities culminate in the highly diverse features of the disorder. Candidate pathways must be able to account for the developmental and deteriorative clinical profiles and the global and focal neuropsychological deficits, as well as the various patho-anatomical abnormalities that indicate aberrant cytoarchitecture and connectivity in the absence of neurodegeneration or other obvious evidence of postmaturational neural injury.

Entities:  

Mesh:

Year:  1999        PMID: 10225332     DOI: 10.1111/j.1600-0447.1999.tb05982.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand Suppl        ISSN: 0065-1591


  4 in total

1.  Increased SNARE Protein-Protein Interactions in Orbitofrontal and Anterior Cingulate Cortices in Schizophrenia.

Authors:  Alfredo Ramos-Miguel; Clare L Beasley; Andrew J Dwork; J John Mann; Gorazd Rosoklija; Alasdair M Barr; William G Honer
Journal:  Biol Psychiatry       Date:  2014-12-19       Impact factor: 13.382

2.  Sex differences in microglial colonization and vulnerabilities to endocrine disruption in the social brain.

Authors:  Meghan E Rebuli; Paul Gibson; Cassie L Rhodes; Bruce S Cushing; Heather B Patisaul
Journal:  Gen Comp Endocrinol       Date:  2016-04-19       Impact factor: 2.822

3.  Cognitive neurosciences: A new paradigm in management and outcome of schizophrenia.

Authors:  Amresh K Shrivastava; Megan E Johnston
Journal:  Indian J Psychiatry       Date:  2010-04       Impact factor: 1.759

4.  Chronic olanzapine administration causes metabolic syndrome through inflammatory cytokines in rodent models of insulin resistance.

Authors:  Huqun Li; Shiyong Peng; Shihong Li; Shouqing Liu; Yifan Lv; Ni Yang; Liangyu Yu; Ya-Hui Deng; Zhongjian Zhang; Maosheng Fang; Yunxiang Huo; Ying Chen; Taohua Sun; Weiyong Li
Journal:  Sci Rep       Date:  2019-02-07       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.